Olodaterol is primarily used as a long-acting beta-2 adrenergic agonist (LABA) for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It helps to relax the muscles in the airways, improving breathing in patients with conditions like chronic bronchitis and emphysema. The medication is typically administered via inhalation, ensuring it acts directly on the lungs for effective relief of symptoms such as shortness of breath, wheezing, and coughing. It is often used as part of a combination therapy with other medications like tiotropium to enhance its efficacy in managing COPD. Regular use of olodaterol can help reduce the frequency of COPD exacerbations, improving overall quality of life for patients.